The ubiquitin-proteasome system: potential therapeutic targets for Alzheimer's disease and spinal cord injury
B Gong, M Radulovic… - Frontiers in molecular …, 2016 - frontiersin.org
The ubiquitin-proteasome system (UPS) is a crucial protein degradation system in
eukaryotes. Herein, we will review advances in the understanding of the role of several …
eukaryotes. Herein, we will review advances in the understanding of the role of several …
[HTML][HTML] Emerging topics in C. elegans aging research: Transcriptional regulation, stress response and epigenetics
MS Denzel, LR Lapierre, HID Mack - Mechanisms of ageing and …, 2019 - Elsevier
Key discoveries in aging research have been made possible with the use of model
organisms. Caenorhabditis elegans is a short-lived nematode that has become a well …
organisms. Caenorhabditis elegans is a short-lived nematode that has become a well …
Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic protease DDI-1
NJ Lehrbach, G Ruvkun - elife, 2016 - elifesciences.org
Proteasomes are essential for protein homeostasis in eukaryotes. To preserve cellular
function, transcription of proteasome subunit genes is induced in response to proteasome …
function, transcription of proteasome subunit genes is induced in response to proteasome …
Endoplasmic reticulum-associated SKN-1A/Nrf1 mediates a cytoplasmic unfolded protein response and promotes longevity
NJ Lehrbach, G Ruvkun - Elife, 2019 - elifesciences.org
Unfolded protein responses (UPRs) safeguard cellular function during proteotoxic stress
and aging. In a previous paper (Lehrbach and Ruvkun, 2016) we showed that the ER …
and aging. In a previous paper (Lehrbach and Ruvkun, 2016) we showed that the ER …
Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome
Proteasomes are central regulators of protein homeostasis in eukaryotes. Proteasome
function is vulnerable to environmental insults, cellular protein imbalance and targeted …
function is vulnerable to environmental insults, cellular protein imbalance and targeted …
Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration
A protein's structure is determined by its amino acid sequence and post-translational
modifications, and provides the basis for its physiological functions. Across all organisms …
modifications, and provides the basis for its physiological functions. Across all organisms …
Age-and hypertension-associated protein aggregates in mouse heart have similar proteomic profiles
S Ayyadevara, F Mercanti, X Wang, SG Mackintosh… - …, 2016 - Am Heart Assoc
Neurodegenerative diseases are largely defined by protein aggregates in affected tissues.
Aggregates contain some shared components as well as proteins thought to be specific for …
Aggregates contain some shared components as well as proteins thought to be specific for …
Glial fibrillary acidic protein: a biomarker and drug target for alzheimer's disease
Glial fibrillary acidic protein (GFAP) is an intermediate filament structural protein involved in
cytoskeleton assembly and integrity, expressed in high abundance in activated glial cells …
cytoskeleton assembly and integrity, expressed in high abundance in activated glial cells …
Immunoproteasome deficiency alters microglial cytokine response and improves cognitive deficits in Alzheimer's disease-like APPPS1 mice
LK Wagner, KE Gilling, E Schormann… - Acta neuropathologica …, 2017 - Springer
The immunoproteasome (iP) represents a specialized type of proteasomes, which plays an
important role in the clearance of oxidant-damaged proteins under inflammatory and …
important role in the clearance of oxidant-damaged proteins under inflammatory and …
Establishment of a suite of assays that support the discovery of proteasome stimulators
Background The proteasome catalyzes the degradation of many mis-folded proteins, which
are otherwise cytotoxic. There is interest in the discovery of proteasome agonists, but …
are otherwise cytotoxic. There is interest in the discovery of proteasome agonists, but …